Is It Time To Reassess Edgewell Personal Care (EPC) After Recent Share Price Rebound?

• If you are wondering whether Edgewell Personal Care is attractively priced or not, this article will walk through the key numbers that matter for value focused investors.
• The share price closed at US$21.40 recently, with returns of 10.0% over the last 30 days and 26.9% year to date, but a 28.3% decline over the last year and a 46.3% decline over three years show a mixed picture.
• These moves come as the company continues to operate in the household and personal care space, where brands and consumer habits can influence how investors think about growth potential and risk. With this context in mind, it is worth checking whether the current share price still lines up with the underlying fundamentals.
• On Simply Wall St’s valuation checks, Edgewell Personal Care scores 5/6 for being undervalued, so we will walk through what different valuation approaches say about the stock, then finish with a more rounded way to think about valuation beyond a single score.

Find out why Edgewell Personal Care's -28.3% return over the last year is lagging behind its peers.

Approach 1: Edgewell Personal Care Discounted Cash Flow (DCF) Analysis

A Discounted Cash Flow, or DCF, model projects a company’s future cash flows and then discounts them back to today’s value to estimate what the business might be worth per share.

For Edgewell Personal Care, the model used is a 2 Stage Free Cash Flow to Equity approach, based on cash flows available to shareholders. The latest twelve month Free Cash Flow is about $46.9 million, and Simply Wall St builds out a path of future Free Cash Flow using analyst inputs where available, then extends those projections further using its own assumptions. For example, one of the later points in the model is a projected Free Cash Flow of $198.7 million in 2035.

When all these projected cash flows are discounted back to today and adjusted for the number of shares, the DCF model arrives at an estimated intrinsic value of about $48.23 per share. Compared with the recent share price of $21.40, this implies the stock is 55.6% undervalued based on this method alone.

Result: UNDERVALUED

Our Discounted Cash Flow (DCF) analysis suggests Edgewell Personal Care is undervalued by 55.6%. Track this in your watchlist or portfolio, or discover 45 more high quality undervalued stocks.

Head to the Valuation section of our Company Report for more details on how we arrive at this Fair Value for Edgewell Personal Care.

Approach 2: Edgewell Personal Care Price vs Sales

For a profitable company that is already generating revenue, the price to sales, or P/S, multiple is a useful cross check on valuation because it links what investors are paying directly to the sales the business is producing today.

In general, higher expected growth and lower perceived risk can justify a higher “normal” or “fair” P/S ratio, while slower expected growth or higher risk tend to support a lower multiple. So the context around the number matters as much as the number itself.

Edgewell Personal Care currently trades on a P/S ratio of 0.45x, compared with the Personal Products industry average of about 0.85x and a peer average of 1.03x. Simply Wall St’s Fair Ratio for Edgewell is 0.67x, which is its proprietary view of what the P/S ratio could be based on factors such as earnings growth, industry, profit margin, market cap and company specific risks.

This Fair Ratio can be more informative than a simple comparison to peers or the industry because it adjusts for the company’s own growth profile, risk characteristics and profitability rather than assuming one size fits all. With the current P/S of 0.45x sitting below the Fair Ratio of 0.67x, the P/S framework points to the stock looking undervalued on this metric.

Result: UNDERVALUED

P/S ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 19 top founder-led companies.

Upgrade Your Decision Making: Choose your Edgewell Personal Care Narrative

Earlier we mentioned that there is an even better way to understand valuation. On Simply Wall St’s Community page you can use Narratives to link your view of Edgewell Personal Care’s story to concrete forecasts and a Fair Value. You can then compare that Fair Value to the current price in real time as news or earnings arrive, and see how different investors can reasonably land anywhere from a cautious US$21.00 view to a more optimistic US$31.40 view based on their own revenue, margin and P/E assumptions.

For Edgewell Personal Care, however, we will make it really easy for you with previews of two leading Edgewell Personal Care narratives:

🐂 Edgewell Personal Care Bull Case

Fair value: about US$31.40 per share

Implied discount to fair value vs last close of US$21.40: roughly 31.8% undervalued using the narrative fair value

Revenue growth assumption: about 1.88% a year

• Leans on international sales, cost savings and a refreshed US commercial setup to support higher margins and cash generation over time.
• Assumes earnings reach about US$260.7m by 2028, with margins lifting and a lower future P/E of 7.9x applied to those earnings.
• Builds in ongoing buybacks, a lower discount rate and a trimmed but still higher fair value of roughly US$31.40, while flagging execution and category risks for investors to weigh.

🐻 Edgewell Personal Care Bear Case

Fair value: about US$21.00 per share

Implied premium to fair value vs last close of US$21.40: roughly 1.9% overvalued using the narrative fair value

Revenue growth assumption: about 3.98% long run decline

• Focuses on pressure from changing consumer preferences, private label competition, e commerce trends and higher input costs that could limit growth and margins.
• Assumes earnings of about US$240.0m by 2028 with profit margins around 11.24%, but values those earnings at a low future P/E of 5.65x.
• Keeps fair value at about US$21.00 and highlights that even with improving operations and buybacks, analysts in this camp see the current market expectations as slightly too optimistic.

If you want to see how other investors frame these trade offs between growth, margins and valuation for Edgewell, you can read the full bull and bear narratives alongside the data that sits behind them, including Curious how numbers become stories that shape markets? Explore Community Narratives.

Do you think there's more to the story for Edgewell Personal Care? Head over to our Community to see what others are saying!

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com